Overview of 5 FDA Priority Review PDUFA decision dates in September 2026, covering novel treatments in rare neurological disorders, oncology, and adolescent cardiology.

The VA is launching a clinical trial to see if GLP-1 RAs can help reduce alcohol use disorder incidence among veterans.

Over 50 million road injury incident cases in 2023 prompt health experts to look at road safety as a public health priority.

Frontotemporal dementia may receive delayed diagnosis and may be reported differently among Hispanic patients due to potential systemic barriers.

Food processing levels do not seem to affect adverse outcomes associated with healthy vs unhealthy plant-based diets.

Embedded clinical psychologists in medical intensive care units (MICUs) most frequently provide family-centered psychologic support and management of adjustment, coping, anxiety, and depression, ...

Increased cigarette and e-cigarette use may be indirectly related to higher levels of sociopolitical stress in Mexican American young adults.

Significant sex differences exist in the prevalence of specific mental health disorders and substance use behaviors among patients with methamphetamine use disorder.

In an 8-week trial, oral semaglutide reduced heavy drinking days, day-to-day alcohol cravings, and alcohol consumption per occasion in AUD.

Semaglutide sustains lower calorie intake for more than a year, even as feelings of hunger gradually return, according to a study published in the August issue ...

Polygenic risk scores for conditions like ADHD and autism are less predictive in non-European populations, highlighting a need for diversity.

Federal authorities convicted a telehealth company founder and clinical president for illegal stimulant prescription ...